EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol.100, pp.56-61, 2022 (SCI-Expanded)
Background: Mucormycosis is an emerging aggressive mold infection. This study aimed to assess the outcome of hospitalized adults with rhino-orbito-cerebral mucormycosis (ROCM). The secondary objective was to identify prognostic factors in this setting.